# ClinicalTrials.gov record NCT00730171

> PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct00730171-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-02-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00730171-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00730171-linaclotide-v1.json
- Content SHA-256: `e0a8b01c5e37ca6d3ac9d70473c7158e224929082dac7528d3c96203d225142e`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00730171 ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

## Sources

<a id="source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe"></a>
- **ClinicalTrials.gov record NCT00730171 · retained source version 2018-02-19:000ab9dd65feb70bfb1714ee9240738c5005e75f16ad36580110336999d663b8** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00730171) (`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00730171." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00730171-linaclotide-v1.json SHA-256: e0a8b01c5e37ca6d3ac9d70473c7158e224929082dac7528d3c96203d225142e.